REGENT PACIFIC GROUP (00575.HK): Expected to Swing to Profit in First Half
NewTimeSpace News: On August 3, 2026,REGENT PACIFIC GROUP(00575.HK) issued a positive profit forecast. Based on preliminary assessment of unaudited consolidated management accounts, the Group expects to register a profit ranging from approximately US$500,000 to US$1 million during the reporting period, compared with a loss of about US$2.22 million in the corresponding period of last year.
According to the announcement, the improved profitability is mainly attributable to a net milestone payment of US$4.5 million received from Fosun Wanbang following the approval of the New Drug Application for Senstend™.
NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.
- Regent Pacific Group (00575.HK): Senstend™ Approved for Marketing by National Medical Products Administration
- REGENT PACIFIC(00575.HK): Deep Longevity Blood Biological Age Model Proven to Predict Mortality and Hospitalisation Risks in Research
- REGENT PACIFIC(00575.HK): Wholly-owned Subsidiary Deep Longevity Named Runner-up in Nestlé VITAL Smart Aging Global Challenge
- REGENT PACIFIC(00575.HK) closed 78.95% higher on Jun 17, leading the Hang Seng Pharmaceuticals & Biotechnology Sector